Comparison

Human CD123 Monoclonal Antibody European Partner

Item no. YR0023-20mg
Manufacturer Abclonal
Amount 20 mg
Quantity options 1 mg 20 mg 5 mg
Category
Applications ELISA, FA, NT
Specific against other
Isotype IgG1 Kappa
Purity >95% Determined by SDS-PAGE
NCBI CD123
Alias IL3R,IL3RX,IL3RY,IL3RAY,hIL-3Ra,IL-3R-alpha,IL3RA
Available
Manufacturer - Applications
ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways
Manufacturer - Category
Biosimilar
Manufacturer - Conjugate / Tag
<5% Determined by SECP
Storage Conditions
2 - 8°C for up to 4 weeks and -80°C for long term storage (Avoid repeated freezing and thawing)
Background
Pivekimab is a human IgG1 monoclonal antibody that targets interleukin-3 (IL-3) and CD123. Pivekimab is used to synthesize pivekimab sunirine, a CD123-directed antibody-active molecule conjugate (ADC). Pivekimab is used in the study of blastic plasmacytoid dendritic cell neoplasm (BPDCN).
Manufacturer - Cross Reactivity
<1EU/mg (<0.001EU/μg)Determined by LAL gel clotting assay
Route
1×PBS pH 7.0
Gene Symbol
CD123

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 20 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close